Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

被引:4
|
作者
Chen, Xi [1 ]
Guo, Jishu [2 ]
Zhou, Fan [3 ]
Ren, Wenjun [4 ]
Huang, Xiaobin [1 ]
Pu, Jun [1 ]
Niu, Xiaoqun [5 ]
Jiang, Xiulin [6 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 2, Dept Neurosurg, Kunming, Peoples R China
[2] Yunnan Univ, Inst forEcol Res & Pollut Control Plateau Lakes, Sch Ecol & Environm Sci, Kunming, Peoples R China
[3] Puer Peoples Hosp, Hematol & Rheumatol Dept, Puer, Peoples R China
[4] First Peoples Hosp Yunnan Prov, Dept Cardiovasc Surg, Kunming, Peoples R China
[5] Kunming Med Univ, Second Hosp, Dept Resp Med, Kunming, Peoples R China
[6] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
AL139385; 1; lung adenocarcinoma; prognosis biomarker; DNA methylation; ceRNA; cell proliferation; cell migration; CELL-PROLIFERATION; CANCER; RETRACTION; EXPRESSION;
D O I
10.3389/fonc.2022.905871
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung adenocarcinoma (LUAD) is the most common histological lung cancer, and it is the leading cause of cancer-related deaths worldwide. LncRNA-AL139385.1 (ENSG00000275880) is a novel lncRNA that is abnormally expressed in various cancer types including LUAD. However, the underlying biological function and potential mechanisms of AL139385.1 driving the progression of LUAD remain unclear. In this study, we investigated the role of AL139385.1 in LUAD and found that DNA hypomethylation was positively correlated with AL139385.1 expression in LUAD. Moreover, we uncover that the expression of AL139385.1 in LUAD tissues was significantly higher than that of AL139385.1 expression in adjacent normal tissues. Kaplan-Meier survival analysis showed that patients with higher AL139385.1 expression correlated with adverse overall survival and progression-free survival. Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) value of AL139385.1 was 0.808. Correlation analysis showed that AL139385.1 expression was associated with immune infiltration in LUAD. We also found that AL139385.1 was upregulated in LUAD cancer tissues and cell lines. Knockdown of AL139385.1 significantly inhibited cell proliferation and migration abilities of LUAD. Finally, we constructed a ceRNA network that includes hsa-miR-532-5p and four mRNAs (GALNT3, CYCS, EIF5A, and ITGB4) specific to AL139385.1 in LUAD. Subsequent Kaplan-Meier survival analysis suggested that polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), cytochrome c, somatic (CYCS), eukaryotic translation initiation factor 5A (EIF5A), and integrin subunit beta 4 (ITGB4), were potential prognostic biomarkers for patients with LUAD. In conclusion, this finding provides possible mechanisms underlying the abnormal upregulation of AL139385.1 as well as a comprehensive view of the AL139385.1-mediated competing endogenous RNAs (ceRNA) network in LUAD, thereby highlighting its potential role in diagnosis and therapy.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma
    Salavaty, Abbas
    Rezvani, Zahra
    Najafi, Ali
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (08) : 5600 - 5617
  • [42] Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease
    Yang, Yujia
    Cai, Yue
    Wu, Gengze
    Chen, Xinjian
    Liu, Yukai
    Wang, Xinquan
    Yu, Junyi
    Li, Chuanwei
    Chen, Xiongwen
    Jose, Pedro A.
    Zhou, Lin
    Zeng, Chunyu
    CLINICAL SCIENCE, 2015, 129 (08) : 675 - 685
  • [43] Long Non-Coding RNA ZFAS1 as a Novel Potential Biomarker for Predicting the Prognosis of Thyroid Cancer
    Han, Chuan-Gang
    Huang, Yan
    Qin, Lu
    MEDICAL SCIENCE MONITOR, 2019, 25 : 2984 - 2992
  • [44] Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD
    Ren, Wenjun
    Yuan, Yixiao
    Chen, Xi
    Zhai, Haoqing
    An, Yin
    Tang, Lin
    Wang, Juan
    Zhang, Dahang
    Zhang, Liren
    Cheng, Wanli
    Wang, Xin
    Duan, Lincan
    Mutti, Luciano
    Han, Bin
    Wang, Ping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Long non-coding RNA HOXA transcript at the distal tip as a biomarker for gastric cancer
    Yang, Yuchong
    Ma, Bin
    Yan, Ying
    Song, Yongxi
    Gao, Peng
    Sun, Jingxu
    Wang, Jiajun
    Wang, Zhenning
    ONCOLOGY LETTERS, 2017, 14 (01) : 1068 - 1072
  • [46] Long non-coding RNA SAMMSON as a novel potential diagnostic and prognostic biomarker for oral squamous cell carcinoma
    Zheng, Xijiao
    Tian, Xia
    Zhang, Qiao
    Shi, Ping
    Li, Shu
    JOURNAL OF DENTAL SCIENCES, 2020, 15 (03) : 329 - 335
  • [47] The combined use of long non-coding RNA HOTAIR and polycomb group protein EZH2 as a prognostic marker of lung adenocarcinoma
    Iizuka, Toshihiko
    Nagano, Hiroko
    Nomura, Kimie
    Hiramatsu, Miyako
    Motoi, Noriko
    Mun, Mingyon
    Ishikawa, Yuichi
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 31
  • [48] Identification of a long non-coding RNA signature associated with cuproptosis for prognosis and immunotherapy response prediction in patients with lung adenocarcinoma
    Zeng, Jie
    Wu, Zhenyu
    Luo, Meijuan
    Chen, Zhibo
    Xu, Xie
    Xie, Guijing
    Chen, Quhai
    Bai, Wenjie
    Xiao, Gang
    Xie, Jianjiang
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [49] Evaluation of the clinical significance of long non-coding RNA MALAT1 genetic variants in human lung adenocarcinoma
    Lin, Shu-Hui
    Lu, Jeng-Wei
    Hsieh, Wang -Ting
    Chou, Ying-Erh
    Su, Tzu-Cheng
    Tsai, Tun-Jen
    Tsai, Yun-Jung
    Yang, Po-Jen
    Yang, Shun -Fa
    AGING-US, 2024, 16 (06): : 5740 - 5750
  • [50] Long non-coding RNA in prostate cancer
    An, Christine
    Wang, Ian
    Li, Xin
    Xia, Rong
    Deng, Fangming
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (03): : 170 - 179